Mouse Anti-HIV-1 Env Recombinant Antibody (clone 3B3) (CAT#: MRO-2818CQ)

Recombinant mouse antibody to Env. 3B3 bound the Env proteins with high affinity, but did not neutralize any of the tier 1 and tier 2 subtype B and C viruses.

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Formats:

  • Isotype Switching:

  • Fc Engineering:

  • Modalities:

Custom Production

We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

Sequences:
Isotype :
Purity :
Endotoxin :
Quantity :
Conjugation :
Fc Engineering :
Modalities :
Other Requirements:
We require custom production
  • Published Data
  • Datasheet
  • MSDS
  • COA
Cyt

Figure 4 Increased activity of immunotoxins with an aromatic substitution at position 100e of CDR H3.

Figure 4 Increased activity of immunotoxins with an aromatic substitution at position 100e of CDR H3.

Env⁺and Env⁻ CHO cells were incubated with various concentrations of the indicated 3B3(scFv)-PE immunotoxins for 48 h and then stained with MTT. The averages for duplicate determinations at 48 h normalized to 100% for no immunotoxin are shown.

Increased Affinity and Stability of an Anti-HIV-1 Envelope Immunotoxin by Structure-based Mutagenesis

FC

Figure 5 FACS analysis of immunotoxin binding to the cell surface.

Figure 5 FACS analysis of immunotoxin binding to the cell surface.

HeLa cells were infected with vaccinia virus recombinants carrying the indicated HIV-1 env gene or with vector alone.

Increased Affinity and Stability of an Anti-HIV-1 Envelope Immunotoxin by Structure-based Mutagenesis

Cyt

Figure 6 Biochemical stability of immunotoxins.

Figure 6 Biochemical stability of immunotoxins.

Freshly purified 3B3(scFv)-PE was incubated in PBS for various intervals, and samples were analyzed by FPLC on a TSK G3000SW column.

Increased Affinity and Stability of an Anti-HIV-1 Envelope Immunotoxin by Structure-based Mutagenesis

Inhib

Figure 7 Inhibition of Env-mediated cell fusion.

Figure 7 Inhibition of Env-mediated cell fusion.

HeLa cells were infected with recombinant vaccinia viruses carrying the indicated env gene and a T7 promoter·β-galactosidase gene.

Increased Affinity and Stability of an Anti-HIV-1 Envelope Immunotoxin by Structure-based Mutagenesis

Inhib

Figure 8 Inhibition of spreading infection of PBMC by N31H/Q100eY(scFv)-PE.

Figure 8 Inhibition of spreading infection of PBMC by N31H/Q100eY(scFv)-PE.

PBMC from healthy human donors were infected with HIV-1˪ₐᵥ and incubated in the presence of 0, 3.3, 33, 325, or 3250 ng/ml of N31H/Q100eY(scFv)-PE or with 325 ng/ml of 3B3(scFv)-PEₐₛₚ₅₃₃ for a total of 14 days.

Increased Affinity and Stability of an Anti-HIV-1 Envelope Immunotoxin by Structure-based Mutagenesis


Specifications

  • Host Species
  • Mouse
  • Type
  • Mouse IgG
  • Specificity
  • Recognizes HIV-1 Env
  • Species Reactivity
  • HIV-1
  • Clone
  • 3B3
  • Applications
  • ELISA, WB, SPR, FC, Cyt, Inhib, IF

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • The HIV-1 Env antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Western Blot, Surface Plasmon Resonance, Flow Cytometry, Cytotoxicity, Inhibition, Immunofluorescence.

Target

  • Alternative Names
  • ENV; gp160; envelope glycoprotein; Envelope surface glycoprotein gp160; precursor; hypothetical protein; Envelope surface glycoprotein gp120; Envelope transmembrane domain

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "HIV-1 Env"

Select a product category from the dropdown menu below to view related products.
Please select product type
Single Domain Antibodies ScFv Antibodies IgG Antibodies MHC Tetramers for Virology IgM Antibodies Fab Antibodies ScFv-Fc Chimeras
CAT Product Name Application Type
NABG-057 Recombinant Anti-HIV-1 env VHH Single Domain Antibody ELISA, IHC, FC, FuncS Llama VHH

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for MRO-2818CQ. Click the button above to contact us or submit your feedback about this product.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# MRO-2818CQ, RRID: AB_3111539)

Copy citation

Popular products with customers


For Research Use Only. Not For Clinical Use.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare